Ahead of print
Research paper (original)
Published online: 2024-04-26

open access

Page views 42
Article views/downloads 26
Get Citation

Connect on Social Media

Connect on Social Media

HPV vaccination coverage in the European Region

Mariola Borowska1, Pawel Koczkodaj1, Marta Mańczuk1


Introduction. Human papillomavirus (HPV) is an established cause of cervical cancer and other HPV-related diseases. This study aims to analyze the variation in coverage by HPV vaccination programs, particularly within the European Region countries, and explore possible health outcomes.
Material and methods. A comprehensive literature review and analysis of epidemiological data were conducted, focusing on HPV vaccination coverage rates, the implementation of vaccination programs, and their outcomes across the EU/EEA. The study examined various vaccination models, including school-based and health center-based programs, to understand their effectiveness in achieving high vaccination coverage and the associated reduction in HPV-related disease burden.
Results. The study's analysis identified significant variations in HPV vaccination coverage across the EU/EEA. School-based vaccination programs, in particular, were found to be highly effective in reaching the target population, achieving coverage rates significantly higher than those observed in countries relying on health center-based or mixed-model vaccination strategies.
Conclusions. HPV vaccination programs have played a crucial role in reducing the burden of HPV-related diseases. These programs' success largely depends on achieving high vaccination coverage, which is more effectively realized through school-based vaccination strategies.

Article available in PDF format

View PDF Download PDF file

Nowotwory. Journal of Oncology